199 participants
Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-08-01
- Start Date:
- 2016-06-14
- Completion:
- 2021-09-13
Conditions
- Advanced or Metastatic ER+ Breast Cancer
Interventions
- DRUG
No Results Yet